The American Cancer Society has issued new guidelines to help primary care physicians (PCPs) get up to speed in the management of survivors.
The guidance is greatly needed because the care of these men increasingly falls to PCPs.
In the United States, the number of prostate cancer survivors is approaching 2.8 million, which represents 1 in 5 of all American cancer survivors, write the guideline team, led by senior author Rebecca Cowens-Alvarado, MPH, director, Cancer Control Mission Strategy, American Cancer Society.
Oncologists cannot keep up with this ballooning population.
Medscape Medical News.
"There is a shrinking number of oncology providers to care for newly diagnosed patients," Cowens-Alvarado said in an interview with
Read the report here: http://bit.ly/1tckh3f
Source: Medscape
Osimertinib Demonstrates Overall Survival Benefit as Adjuvant Lung Cancer Treatment
March 19th 2023Osimertinib (Tagrisso; AstraZeneca) now has shown a statistically significant and clinically meaningful overall survival benefit in both the early adjuvant and late-stage metastatic settings.
Read More
Even Oncologists Sold on Value-Based Care Hesitate to Embrace the EOM
March 10th 2023Members of the Association of Community Cancer Centers (ACCC) Alternative Payment Coalition discussed strategies for succeeding in value-based care and voiced concerns surrounding the upcoming Enhancing Oncology Model (EOM) during a panel discussion at the ACCC 2023 Annual Meeting and Business Summit.
Read More
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
Multicancer Early Detection May Change the Screening Game—If We Learn From the Past
March 9th 2023A session at the ACCC 2023 Annual Meeting and Cancer Center Business Summit addressed the promise and potential drawbacks of multicancer early detection (MCED) testing for patients in the primary care setting.
Read More
2 Clarke Drive
Cranbury, NJ 08512